Evidence map›Paper›PMID 24587077›Full record

ArticlePloS one2014

Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France.

Dieynaba S N'Diaye, Yazdan Yazdanpanah, Anne Krivine, Thibaut Andrieu, Flore Rozenberg, Olivier Picone, Vassilis Tsatsaris, François Goffinet, Odile Launay

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection at a Single Center.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dieynaba S N'DiayeInfection, Antimicrobiens, Modélisation, Evolution (IAME), Unité Mixte de Recherche (UMR) 1137, Institut National de la Santé et de la Recherche Médicale (INSERM), Université (Univ) Paris Diderot, Sorbonne Paris Cité, Paris, France ; Université Pierre et Marie Curie (UPMC) Univ Paris 06, École doctorale (ED)393, Paris, France.
Yazdan YazdanpanahInfection, Antimicrobiens, Modélisation, Evolution (IAME), Unité Mixte de Recherche (UMR) 1137, Institut National de la Santé et de la Recherche Médicale (INSERM), Université (Univ) Paris Diderot, Sorbonne Paris Cité, Paris, France ; Assistance-Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalier Bichat-Claude Bernard, Hôpitaux Universitaires Paris Nord Val de Seine (HUPNVS), Service des Maladies Infectieuses, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Anne KrivineAP-HP, Groupe Hospitalier Cochin-Broca-Hôtel Dieu, Département de Virologie, Paris, France.
Thibaut AndrieuINSERM Unité (U)953, Recherche Epidémiologique en Santé Périnatale et Santé des Femmes et des Enfants, Université Pierre-et-Marie-Curie, Paris, France.
Flore RozenbergAP-HP, Groupe Hospitalier Cochin-Broca-Hôtel Dieu, Département de Virologie, Paris, France ; Université Paris Descartes, Paris Sorbonne Cité, Paris, France.
Olivier PiconeHôpital Foch, Maternité, Suresnes, France.
Vassilis TsatsarisUniversité Paris Descartes, Paris Sorbonne Cité, Paris, France ; AP-HP, Hôpital Cochin, Maternité, Paris, France.
François GoffinetINSERM Unité (U)953, Recherche Epidémiologique en Santé Périnatale et Santé des Femmes et des Enfants, Université Pierre-et-Marie-Curie, Paris, France ; Université Paris Descartes, Paris Sorbonne Cité, Paris, France ; AP-HP, Hôpital Cochin, Maternité, Paris, France ; INSERM Centre d'Investigation Clinique (CIC) P0901, Paris, France.
Odile LaunayUniversité Paris Descartes, Paris Sorbonne Cité, Paris, France ; INSERM, CIC BT505, Paris, France ; AP-HP, Hôpital Cochin, CIC de Vaccinologie Cochin-Pasteur, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCytomegalovirus (CMV) is the most frequent cause of congenital infection. The objective of this study was to evaluate predictive factors for CMV seronegativity in a cohort of pregnant women in Paris, France.

methodsPregnant women enrolled in a prospective cohort during the 2009 A/H1N1 pandemic were tested for CMV IgG antibodies. Variables collected were age, geographic origin, lifestyle, work characteristics, socioeconomic status, gravidity, parity and number of children at home. A multivariate logistic regression model was used to identify independent predictive factors for CMV seropositivity.

resultsAmong the 826 women enrolled, 389 (47.1%) were primiparous, and 552 (67.1%) had Metropolitan France as a geographic origin. Out of these, 355 (i.e. 57.0%, 95% confidence interval (CI): [53.6%-60.4%]) were CMV seropositive: 43.7% (95% CI:[39.5%-47.9%]) in those whose geographic origin was Metropolitan France and 84.1% in those with other origins (95% CI:[79.2%-88.3%]). Determinants associated with CMV seropositivity in a multivariate logistic regression model were: (i) geographic origin (p<0.001(compared with Metropolitan France, geographic origins of Africa adjusted odds ratio (aOR) 21.2, 95% CI:[9.7-46.5], French overseas departments and territories and other origin, aOR 7.5, 95% CI:[3.9-14.6], and Europe or Asia, aOR 2.2, 95% CI: [1.3-3.7]); and (ii) gravidity (p = 0.019), (compared with gravidity = 1, if gravidity≥3, aOR = 1.5, 95% CI: [1.1-2.2]; if gravidity = 2, aOR = 1.0, 95% CI: [0.7-1.4]). Work characteristics and socioeconomic status were not independently associated with CMV seropositivity.

conclusionsIn this cohort of pregnant women, a geographic origin of Metropolitan France and a low gravidity were predictive factors for CMV low seropositivity. Such women are therefore the likely target population for prevention of CMV infection during pregnancy in France.

Indexed as

Seroepidemiologic StudiesAge FactorsAntibodies, ViralCohort StudiesCytomegalovirus InfectionsEthnicityFemaleGravidityHumansLogistic ModelsOdds RatioParisParityPregnancyProspective StudiesRisk FactorsAntibodies, Viral

Identifiers

PMID24587077
PMCPMC3933677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.